Emyria
EM
EM

Emyria

ClaimedAgent28Agent Readiness: 28/100. Bottom 25%. Measured by StartupHub.ai. Median 41.Trust56Data Trust: 56/100. Below median. Measured by StartupHub.ai. Median 61.

Emyria is a drug development and clinical care company focused on novel treatments for mental health and neurological conditions.

2019ActivePerth, Australia

About

Emyria is an ASX-listed, data-backed drug development and care delivery company focused on unmet needs in mental health and neurological conditions. They combine frontline care with clinical research and real-world data to develop new therapies and breakthrough treatments, including psychedelic-assisted therapies and cannabinoid-based medicines. Emyria operates a network of specialist medical clinics and uses proprietary clinical evidence to accelerate drug development and registration.

Key facts

Website
emyria.com.au
Headquarters
Perth, Australia
Founded
2019
Business model
B2B | B2C

Tech stack

Detected on emyria.com.au, last scanned 19 Oct 2026.

Frontend
Tailwind CSS
CDN
Cloudflare

Emyria scores 28. Does yours?

That is its Agent Readiness: how well ChatGPT, Claude and the other agents can read and use a site. Paste your website and you get yours in about a minute.

Add first review

Frequently asked

Is Emyria trustworthy and reputable?

StartupHub's Data Trust & Reputation score for Emyria is 56 out of 100, a use-caution rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.

Public record

SEC filings, insider activity, nonprofit links and pay benchmarks for Emyria